Suppr超能文献

梅毒性葡萄膜炎的临床表现与转归

Clinical Manifestations and Outcome of Syphilitic Uveitis.

作者信息

Bollemeijer Jan G, Wieringa Wietse G, Missotten Tom O A R, Meenken Ina, ten Dam-van Loon Ninette H, Rothova Aniki, Los Leonoor I

机构信息

Rotterdam Eye Hospital, Rotterdam, The Netherlands 2Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.

Department of Ophthalmology, University Medical Center Groningen, Groningen, The Netherlands 4W. J. Kolff Institute, Graduate School of Medical Sciences, University of Groningen, Groningen, The Netherlands.

出版信息

Invest Ophthalmol Vis Sci. 2016 Feb;57(2):404-11. doi: 10.1167/iovs.15-17906.

Abstract

PURPOSE

To analyze visual outcome, effectiveness of various modes of antibiotic treatment, and prognostic factors in patients with serologically proven syphilitic uveitis.

METHODS

The clinical records of 85 patients (139 eyes) diagnosed with syphilitic uveitis between 1984 and 2013 at tertiary centers in The Netherlands were retrospectively analyzed.

RESULTS

Mean age was 47 years (range, 27-73 years), 82.4% were male. HIV positivity was found in 28 (35.9%) patients; 13 were newly diagnosed. Most patients had pan (45.9%) or posterior (31.8%) uveitis. On average, logMAR visual acuity (VA) improved significantly from 0.55 at the start of syphilis treatment to 0.34 at 1 month and to 0.27 at 6 months follow-up. Most patients (86.7%) reached disease remission. No differences in efficacy between the various treatment regimens were found. A high logMAR VA at the start of syphilis treatment and a treatment delay of more than 12 weeks were prognostic for a high logMAR VA at 6 months follow-up. Chronicity was not related to any form of treatment, HIV status, or Venereal Disease Research Laboratory test outcome.

CONCLUSIONS

In this large cohort of 85 patients with syphilitic uveitis, visual outcomes were favorable in the majority of cases. Visual outcome was dependent on VA at the start of syphilis treatment and treatment delay.

摘要

目的

分析血清学确诊的梅毒性葡萄膜炎患者的视力预后、各种抗生素治疗方式的有效性及预后因素。

方法

回顾性分析1984年至2013年在荷兰三级医疗中心确诊为梅毒性葡萄膜炎的85例患者(139只眼)的临床记录。

结果

平均年龄为47岁(范围27 - 73岁),82.4%为男性。28例(35.9%)患者HIV阳性;13例为新诊断病例。大多数患者患有全葡萄膜炎(45.9%)或后葡萄膜炎(31.8%)。平均而言,logMAR视力在梅毒治疗开始时为0.55,1个月时改善至0.34,随访6个月时改善至0.27,有显著提高。大多数患者(86.7%)病情缓解。未发现不同治疗方案在疗效上有差异。梅毒治疗开始时logMAR视力较高以及治疗延迟超过12周是随访6个月时logMAR视力较高的预后因素。病程与任何形式的治疗、HIV状态或性病研究实验室检测结果均无关。

结论

在这一85例梅毒性葡萄膜炎的大样本队列中,大多数病例的视力预后良好。视力预后取决于梅毒治疗开始时的视力及治疗延迟情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验